-
1دورية أكاديمية
المؤلفون: Peters, S., Stahel, R.A., Dafni, U., Ponce Aix, S., Massutí, B., Gautschi, O., Coate, L., López Martín, A., van Heemst, R., Berghmans, T., Meldgaard, P., Cobo Dols, M., Garde Noguera, J., Curioni-Fontecedro, A., Rauch, D., Mark, M.T., Cuffe, S., Biesma, B., van Henten, AMJ, Juan Vidal, Ó., Palmero Sanchez, R., Villa Guzmán, J.C., Collado Martin, R., Peralta, S., Insa, A., Summers, Y., Láng, I., Horgan, A., Ciardiello, F., de Hosson, S., Pieterman, R., Groen, HJM, van den Berg, P.M., Zielinski, C.C., Chittazhathu Kurian Kuruvilla, Y., Gasca-Ruchti, A., Kassapian, M., Novello, S., Torri, V., Tsourti, Z., Gregorc, V., Smit, E.F.
المساهمون: EMPHASIS-lung Collaborative Group
المصدر: Journal of thoracic oncology, vol. 12, no. 4, pp. 752-762
مصطلحات موضوعية: Aged, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma, Non-Small-Cell Lung/drug therapy, Non-Small-Cell Lung/pathology, Squamous Cell/drug therapy, Squamous Cell/pathology, Cohort Studies, Erlotinib Hydrochloride/administration & dosage, Female, Follow-Up Studies, Humans, Lung Neoplasms/drug therapy, Lung Neoplasms/pathology, Male, Neoplasm Staging, Platinum/administration & dosage, Prognosis, Survival Rate, Taxoids/administration & dosage, Docetaxel, ETOP, Erlotinib, NSCLC, Squamous, VeriStrat
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28017787; info:eu-repo/semantics/altIdentifier/eissn/1556-1380; https://serval.unil.ch/notice/serval:BIB_D30A1C513C0CTest; urn:issn:1556-0864
الإتاحة: https://doi.org/10.1016/j.jtho.2016.12.017Test
https://serval.unil.ch/notice/serval:BIB_D30A1C513C0CTest -
2
المؤلفون: Peters S, Stahel RA, Dafni U, Ponce Aix S, Massutí B, Gautschi O, Coate L, López Martín A, van Heemst R, Berghmans T, Meldgaard P, Cobo Dols M, Garde Noguera J, Curioni-Fontecedro A, Rauch D, Mark MT, Cuffe S, Biesma B, van Henten AMJ, Juan Vidal Ó, Palmero Sanchez R, Villa Guzmán JC, Collado Martin R, Peralta S, Insa A, Summers Y, Láng I, Horgan A, Ciardiello F, de Hosson S, Pieterman R, Groen HJM, van den Berg PM, Zielinski CC, Chittazhathu Kurian Kuruvilla Y, Gasca-Ruchti A, Kassapian M, Novello S, Torri V, Tsourti Z, Gregorc V, Smit EF, EMPHASIS-lung Collaborative Group
المساهمون: Pulmonary medicine, CCA - Cancer Treatment and quality of life, Peters, S, Stahel, Ra, Dafni, U, Aix, Sp, Massutí, B, Gautschi, O, Coate, L, López Martín, A, Van Heemst, R, Berghmans, T, Meldgaard, P, Cobo Dols, M, Noguera, Jg, Curioni Fontecedro, A, Rauch, D, Mark, Mt, Cuffe, S, Biesma, B, Van Henten, Am, Vidal, Ój, Sanchez, Rp, Villa Guzmán, Jc, Martin, Rc, Peralta, S, Insa, A, Summers, Y, Láng, I, Horgan, A, Ciardiello, Fortunato, De Hosson, S, Pieterman, R, Groen, Hj, Van Den Berg, Pm, Zielinski, Cc, Kuruvilla, Yc, Gasca Ruchti, A, Kassapian, M, Novello, S, Torri, V, Tsourti, Z, Gregorc, V, Smit, Ef, EMPHASIS lung collaborative, Group
المصدر: JOURNAL OF THORACIC ONCOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Journal of Thoracic Oncology, 12(4), 752-762. International Association for the Study of Lung Cancer
Peters, S, Stahel, R A, Dafni, U, Ponce Aix, S, Massutí, B, Gautschi, O, Coate, L, López Martín, A, van Heemst, R, Berghmans, T, Meldgaard, P, Cobo Dols, M, Garde Noguera, J, Curioni-Fontecedro, A, Rauch, D, Mark, M T, Cuffe, S, Biesma, B, van Henten, A M J, Juan Vidal, Ó, Palmero Sanchez, R, Villa Guzmán, J C, Collado Martin, R, Peralta, S, Insa, A, Summers, Y, Láng, I, Horgan, A, Ciardiello, F, de Hosson, S, Pieterman, R, Groen, H J M, van den Berg, P M, Zielinski, C C, Chittazhathu Kurian Kuruvilla, Y, Gasca-Ruchti, A, Kassapian, M, Novello, S, Torri, V, Tsourti, Z, Gregorc, V, Smit, E F & EMPHASIS-lung Collaborative Group 2017, ' Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial ', Journal of Thoracic Oncology, vol. 12, no. 4, pp. 752-762 . https://doi.org/10.1016/j.jtho.2016.12.017Test
Peters, S, Stahel, R A, Dafni, U, Ponce Aix, S, Massutí, B, Gautschi, O, Coate, L, López Martín, A, van Heemst, R, Berghmans, T, Meldgaard, P, Cobo Dols, M, Garde Noguera, J, Curioni-Fontecedro, A, Rauch, D, Mark, M T, Cuffe, S, Biesma, B, van Henten, A M J, Juan Vidal, Ó, Palmero Sanchez, R, Villa Guzmán, J C, Collado Martin, R, Peralta, S, Insa, A, Summers, Y, Láng, I, Horgan, A, Ciardiello, F, de Hosson, S, Pieterman, R, Groen, H J M, van den Berg, P M, Zielinski, C C, Chittazhathu Kurian Kuruvilla, Y, Gasca-Ruchti, A, Kassapian, M, Novello, S, Torri, V, Tsourti, Z, Gregorc, V, Smit, E F & EMPHASIS-lung Collaborative Group 2017, ' Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial ', Journal of Thoracic Oncology, vol. 12, no. 4, pp. 752-762 . https://doi.org/10.1016/j.jtho.2016.12.017Test
Journal of Thoracic Oncology, 12(4), 752-762. ELSEVIER SCIENCE INCمصطلحات موضوعية: Oncology, Male, Lung Neoplasms, medicine.medical_treatment, Docetaxel, NSCLC, THERAPY, Squamous, Cohort Studies, RETROSPECTIVE ANALYSIS, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, 3RD-LINE, Antineoplastic Combined Chemotherapy Protocols, VeriStrat, 030212 general & internal medicine, Erlotinib Hydrochloride, ETOP, Prognosis, Survival Rate, Erlotinib, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Female, Taxoids, Veristrat, 2ND-LINE TREATMENT, medicine.drug, Pulmonary and Respiratory Medicine, medicine.medical_specialty, 03 medical and health sciences, Internal medicine, Multicenter trial, medicine, TYROSINE KINASE INHIBITORS, Journal Article, Humans, Lung cancer, COMBINATION, Survival rate, neoplasms, METAANALYSIS, Aged, Neoplasm Staging, Platinum, Chemotherapy, business.industry, medicine.disease, respiratory tract diseases, business, GROWTH-FACTOR RECEPTOR, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee1d367d8bc33b24edc27d000909d5bdTest
https://pubmed.ncbi.nlm.nih.gov/28343541Test -
3دورية أكاديمية
المؤلفون: Peters, S., Stahel, R.A., Dafni, U., Ponce Aix, S., Massutí, B., Gautschi, O., Coate, L., López Martín, A., van Heemst, R., Berghmans, T., Meldgaard, P., Cobo Dols, M., Garde Noguera, J., Curioni-Fontecedro, A., Rauch, D., Mark, M.T., Cuffe, S., Biesma, B., van Henten, AMJ, Juan Vidal, Ó., Palmero Sanchez, R., Villa Guzmán, J.C., Collado Martin, R., Peralta, S., Insa, A., Summers, Y., Láng, I., Horgan, A., Ciardiello, F., de Hosson, S., Pieterman, R., Groen, HJM, van den Berg, P.M., Zielinski, C.C., Chittazhathu Kurian Kuruvilla, Y., Gasca-Ruchti, A., Kassapian, M., Novello, S., Torri, V., Tsourti, Z., Gregorc, V., Smit, E.F.
المساهمون: EMPHASIS-lung Collaborative Group
المصدر: Serveur académique Lausannois ; Journal of thoracic oncology, vol. 12, no. 4, pp. 752-762
العلاقة: urn:issn:1556-0864; 10670/1.5gjd4v; https://serval.unil.ch/notice/serval:BIB_D30A1C513C0CTest
الإتاحة: https://doi.org/10.1016/j.jtho.2016.12.017Test
https://serval.unil.ch/notice/serval:BIB_D30A1C513C0CTest